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Abstract
Ceramides (Cer) comprise the major constituent of sphingolipids in the epidermis and are known to play diverse roles in the outermost layers
of the skin including water retention and provision of a physical barrier. In addition, they can be hydrolyzed into free sphingoid bases such as
C18 sphingosine (SO) and C18  sphinganine (SA) or can be further metabolized to C18  So-1-phosphate (S1P) and C18  Sa-1-phosphate (Sa1P) in keratinocytes.
The significance of ceramide metabolites emerged from studies reporting altered levels of SO and SA in skin disorders and the role of S1P and 
Sa1P as signaling lipids. However, the overall metabolism of sphingoid bases and their phosphates during keratinocyte differentiation remains not
fully understood. Therefore, in this study, we analyzed these Cer metabolites in the process of keratinocyte differentiation. Three distinct keratinocyte
differentiation stages were prepared using 0.07 mM calcium (Ca
2+) (proliferation stage), 1.2 mM Ca
2+  (early differentiation stage) in serum-free
medium, or serum-containing medium with vitamin C (50 μL/mL) (late differentiation stage). Serum-containing medium was also used to determine
whether vitamin C increases the concentrations of sphingoid bases and their phosphates. The production of sphingoid bases and their  phosphates
after hydrolysis by alkaline phosphatase was determined using high-performance liquid chromatography. Compared to cells treated w ith  0.0 7 m M
Ca
2+, levels of SO, SA, S1P, and SA1P were not altered after treatment with 1.2 mM Ca
2+. However, in keratinocytes cultured in serum-containing
medium with vitamin C, levels of SO, SA, S1P, and SA1P were dramatically higher than those in 0.07- and 1.2-mM Ca
2+-treated cells; however,
compared to serum-containing medium alone, vitamin C did not significantly enhance their production. Taken together, we demonstrate that late
differentiation induced by vitamin C and serum was accompanied by dramatic increases in the concentration of sphingoid bases and their phosphates,
although vitamin C alone had no effect on their production.
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Introduction4)
The epidermis is composed of a single layer of basal cells, 
called the basal layer, which, after formation, divide and move 
upward through the stratum spinosum and stratum granulosum 
(SG) to the stratum corneum (SC). This process, known as 
keratinocyte differentiation, is accompanied by sphingolipid 
synthesis. In the SG, synthesized lipids are packaged into 
cytosolic organelles called lamella bodies and are excreted into 
the interface between the SG and the SC. The lipids are then 
incorporated into the SC as ceramides (Cer) [1-3].  Several 
nutrients have been reported to modulate the course of keratinocyte 
differentiation, particularly calcium (Ca
2+) and vitamin C [4-6]. 
A Ca
2+ gradient exists in the epidermis, with the highest levels 
of extracellular Ca
2+  present in the SG, resulting in differentiation 
of this layer [4,7]. In addition, vitamin C is known to enhance 
the late differentiation of keratinocytes by increasing the 
production of certain Cer [5,6]
  .
In the epidermis, Cer have heterogeneity and play diverse roles 
including water retention and the provision of a physical barrier 
between the internal organs and the environment [8,9]. Cer also 
act as precursors for metabolites such as free sphingoid bases 
(sphingosine [SO], sphinganine [SA], phytophingosine, or 
6-hydroxy-SO) [1,10]. Free sphingoid bases have been reported 
to account for 0.5% of the total lipids in the SC; C18 chains 
are known to dominant other chain lengths [11-13]. Specifically, 
C18 SO and C18 SA have been proposed to be associated with 
abnormal skin conditions [13]. C18 SO exerts natural anti- 
inflammatory activity by inhibiting protein kinase C and exerting 
its antimicrobial activity in atopic dermatitis [14-16]. Changes 
in the C18 SA levels in skin diseases such as psoriasis have also 
been reported [13]. In addition, these free sphingoid bases can 
be phosphorylated through the action of SO kinase. Many studies 
have focused on SO 1-phosphate (S1P) rather than SA 1- 
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phosphate (SA1P) because S1P is a bioactive lipid that is 
implicated in keratinocyte growth arrest and differentiation [17]. 
Moreover, it also plays different roles in the epidermis such as 
re-epithelialization of wounds and antimicrobial activity on the 
surfaces of acne lesions [17,18].
Although many studies have focused on the roles of sphingoid 
bases and their phosphates in the epidermis, their metabolism 
during in vitro keratinocyte differentiation remains unclear and 
their levels have not been studied in response to vitamin C, which 
has been shown to stimulate the production of other sphingolipids 
[6]. Therefore, we examined the metabolisms of C18 SO and C18 
SA and their phosphates at different stages of cell differentiation 
using cultured human keratinocytes (CHKs) grown in high 
calcium (early differentiation stage) and serum-containing medium 
with vitamin C (late differentiation stage) [19]. We also investigated 
whether vitamin C alone enhances the production of these 
ceramide metabolites.
Materials and Methods
Materials
Human neonatal epidermal keratinocytes (HEKn) and their 
culture medium and growth supplements were purchased from 
Cascade Biologics (Portland, OR, USA). Dulbecco’s modified 
Eagle’s medium (DMEM) and Ham’s F-12 were obtained from 
GIBCO (San Diego, CA, USA). Insulin and hydrocortisone were 
obtained from Sigma-Aldrich (St. Louis, MO, USA). All 
sphingolipids such as D-erthyro-SO and D-erythro- as external 
stands and D-erythro-C17-SO and D-erythro-C17-SO1-phosphate 
were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, 
USA). The solvents used for high-performance liquid 
chromatography (HPLC) analysis were purchased from Merck 
(Dermstadt, Germany).
Cell culture
Human epidermal keratinocytes were cultured in keratinocyte 
growth medium with bovine pituitary extract (0.2%, v/v), insulin 
(5 μg/mL), hydrocortisone (0.18 μg/mL), bovine transferrin (5 
μg/mL), human epidermal growth factor (0.2 ng/mL), and 0.07 
mM calcium chloride (Cascade Biologics, Portland, OR, USA). 
Cells at 80-90% confluence were either harvested for use as 
keratinocytes in the proliferative stage or were grown further in 
differentiation-inducing medium in two consecutive steps as 
described below [19]. First, early-differentiation keratinocytes 
were generated via culturing cells in medium supplemented with 
1.2 mM calcium and then harvesting after three days. Second, 
late differentiation keratinocytes were obtained by replacing the 
medium with DMEM and Ham’s F-12 (2:1, v/v) containing 1.2 
mM calcium, 10% fetal bovine serum, 10 μg/mL insulin, and 
0.4  μg/mL hydrocortisone, either without or with 50 μg/mL 
vitamin C. Cells were maintained for 11 days, underwent media 
changes three times per week, and were then harvested for the 
experiments. All cultures were maintained at 37℃ in an incubator 
with 5% CO2 in air. 
DNA assay
Following brief sonication, the cell lysates were used for DNA 
determination after treatment with the fluorescent dye bisben-
zimidazole (Bisbenzimide H 33258; Sigma-Aldrich), which binds 
to A-T base pairs in double-stranded DNA. Cell lysates were 
mixed with 200 μL of 0.1 μg/mL bisbenzimide in 1 × fluorescent 
assay buffer [20] (100 mM Tris-HCl [pH 7.4] with 10 mM EDTA 
and 2 M NaCl), and fluorescence was immediately determined 
using a fluorescent plate reader (TECAN, Switzerland) at 
wavelengths of 360 nm for excitation and 460 nm for emission. 
The fluorescence intensity was compared with those of DNA 
standards sodium salt from calf thymus DNA (Sigma-Aldrich) 
with concentrations in the range of 0.1-10 μg/mL. 
Lipid extraction for sphingoid analysis
Cultured cells were rinsed twice with ice-cold phosphate- 
buffered saline (PBS) and harvested via scraping into PBS. After 
centrifugation at 240 × g for 5 min, the pellet was homogenized 
in 500 μL of PBS and ultrasonicated for 10 sec. Cell suspension 
aliquots (50 μL of supernatant) were collected for DNA and 
protein determination. Extraction of sphingoid bases and 
sphingoid base 1- phosphates was performed by addition of 350 
μL of MeOH, 150 μL of 1M NaCl, and 300 μL of CHCl3 to 
the cell homogenates. The pH was then adjusted to 10-11 through 
the addition of 35 μg 3N NaOH to separate the sphingoid bases 
and sphingoid base 1-phosphates to the lower and upper phases, 
respectively. The non-naturally occurring species C17 SO (100 
pmol) and C17 S1P (100 pmol) were added as internal standards, 
and the mixture was vortexed vigorously for 1 h [21,22]. After 
centrifugation at 240 × g for 3 min, the upper phase containing 
the S1P was transferred to a new tube for dephosphorylation, 
while the lower phase was used for free sphingoid base extraction 
as described below. The organic phase was first removed using 
an evaporator and then dissolved in 500 μg of 0.15 M methanolic 
KOH by vortexing for 20 min at 37℃. To this, 500 μg of CHCl3, 
100 μg of 2N NH4OH, and 400 μg of alkaline water were added, 
and the solution was vortexed for 1 h before centrifugal 
separation. After the organic phase containing SO and SA with 
800 μg of alkaline water was washed twice [21], the CHCl3 was 
evaporated using a Speed Vac concentrator (Hanil, Seoul, Korea).
Dephosphorylation of sphingoid base 1-phosphates 
S1P extracted from the aqueous fraction was dephosphorylated 
through the addition of ten units of alkaline phosphatase (New 
England Biolabs, Ipswich, MA, USA) in 100 μL of reaction 398 Analysis ceramide metabolites in calcium vitamin C
DNA (ug/ml) Protein (mg/ml)
Proliferation 2.04 ± 0.23 0.15 ± 0.02
b
Early diff. 2.17 ± 0.07 0.22 ± 0.02
b
Late diff. 2.26 ± 0.21 1.10 ± 0.10
a
Keratinocytes were grown in culture medium with 0.07 mM Ca
2+  (proliferation), 1.2 
mM  Ca
2+ ( e a r ly  d if f . ) ,  a n d  c o n t r o l m e d i u m  c o n t a i n i n g  v i t a m i n  C  ( la t e  d iff.)  as 
described in Materials and Methods. Values are presented as means ± SEM (n =
3).  Means  with  different  letters  are  significantly  different  (P < 0.05)  according  to 
Duncan’s  multiple  range  test.
Table 1. Altered levels of DNA and protein during keratinocyte differentiation
Calcium  0.07 mM  1.2 mM  1.2 mM 
Serum -  -  10% 
Vitamin C  -  -  50 μg/ml 
Fig. 1. Morphological characteristics of keratinocytes in the proliferative and 
early and late different differentiation stages. Cultured human keratinocytes grown 
in  three  different  types  of  medium  were  observed  under  the  microscope  at  a 
magnification  100×.  Cells  in  the  proliferation  stage  were  grown i n  s e r u m - f r e e  
medium with  0.07 mM Ca
2+ for six days and either harvested or induced to the 
e a r l y  d i f f e r e n t i a t i o n  s t a g e  w i t h  1 . 2  m M  C a
2+.  Late  differentiation  was  induced  by 
culturing  cells  in  serum-containing  medium  with  1.2  mM  Ca
2+  and  vitamin  C  (50 
μL/mL).  Late  differentiated  cells  were  maintained  for  11  days,  underwent  media 
changes  three  times  per  week,  and  were  then  harvested. 
buffer (200 mM Tris-HCl [pH 7.4], 7.5 mM MgCl2 in 2M glycine 
buffer, pH 9.0-9.2) and gentle mixing [22]. The enzyme efficiently 
converted sphingoid base 1-phosphates into their corresponding 
sphingoid bases at 37℃ for 2 h. The dephosphorylated sphingoid 
bases were extracted by addition of 600 μL of CHCl3 and 
vortexed for 30 min. After centrifugation at 240 g for 3 min, 
the CHCl3 phase was transferred to a new tube, washed once 
with 800 μL of alkaline water, and then dried in a Speed Vac 
concentrator. 
O-Phtalaldehyde (OPA) derivatization and HPLC analysis
Levels of sphingoid bases and their phosphates were determined 
using HPLC analysis as described below. The extracted lipid 
fraction was resolved in 120 μL of MeOH, followed by the 
addition 20 μL of OPA derivatization (Sigma-Aldrich), 50 mg 
of O-phthaldialdehyde, 1 mL of ethanol, 100 μL of 2-mercap-
toethanol, 50 mL of 3% (w/v) boric acid solution, and a 30-min 
incubation at room temperature [21-23]. OPA is known to react 
with the primary amine groups of sphingoid bases, and it becomes 
highly fluorescent at excitation and emission wavelengths of 340 
nm and 455 nm, respectively. The derivatives were analyzed via 
HPLC equipped with a Jasco PU-980 pump (Tokyo, Japan), a 
Jasco AS-1559 autosampler, and a Jasco FP-920 fluorescence 
detector. The isocratic eluent composition of methanol (deionized 
distilled water (92:8 v/v) with 0.1% triethylamine) was used at 
a flow rate of 1 mL/min, while 70 μL of the derivatives were 
injected and separated on a C18 column (Waters, Sunfire 4.6
× 150 mm ID) at room temperature. Fluorescence of sphingoid 
derivatives was measured at emission and excitation wavelengths 
of 455 nm and 340 nm, respectively [22], to measure the 
concentrations of C17 SO (8.5 min), C 18 SO (10.5 min), and C18 
SA (14.2 min).
Statistical analysis 
Data are expressed as means ± SEM (n = 3). Statistical 
comparisons were conducted using one-way analysis of variance 
followed Duncan’s post-hoc multiple comparison test using SPSS 
18.0 for Windows (SPSS Inc., Chicago, IL, USA) and the 
differences among the groups were determined by Duncan’s 
multiple comparison test. Differences of P< 0.05 were considered 
signiﬁcant.
Results
Morphological characteristics during keratinocyte differentiation
Keratinocytes showed distinct morphological features in the 
differentiation process (Fig. 1). At the proliferative stage induced 
by 0.07 mM Ca
2+, cells grew to confluency as a monolayer of 
non-stratified cells with no detectable intercellular spaces. 
However, when cells at this stage came into contact with their 
neighbors, they did not form well. Cells at the early differentia-
tion stage induced by 1.2 mM Ca
2+ also grew as a monolayer 
but became more compact and grew away from their neighbors. 
Conversely, keratinocytes cultured in serum-containing medium 
with vitamin C grew as multilayered sheets with thicker cell 
layers. Furthermore, after 11 days of cell culture in serum- 
containing medium with vitamin C, the cells secreted a number 
of cytosolic lamella bodies (data not shown). According to 
morphologic criteria, cells cultured in serum-containing medium 
with vitamin C showed a greater differentiation than did those 
grown in high Ca
2+-containing medium without serum or vitamin 
C. 
DNA and protein levels during keratinocyte differentiation
Table 1 shows the changes in total DNA and protein content 
of the keratinocytes in the proliferative and early and late 
differentiation stages. Total protein content increased as cells 
became more differentiated [24]. In particular, increases in 
protein content were significant (P< 0.05) in the late differentia-
tion stage because of a large increase in structural proteins such 
as cornified envelope proteins and keratins, which are known 
to characterize late keratinocyte differentiation [24]. In contrast, 
increases in DNA content were less profound and stayed 
relatively constant during the differentiation process. Juyoung Kim et al. 399
(A)
(B)
Fig. 2. Altered levels of sphingoid bases associated with keratinocyte 
differentiation. Panel A: Sphingosine; Panel B: Sphinganine. Sphingoid bases were 
extracted  from  keratinocytes  grown  in  culture  medium  with  0.07  mM  Ca
2+ 
(proliferation), 1.2 mM Ca
2+ (early d iff.), an d  con trol m ed iu m  co n tain in g  vitam in  C 
(late diff.) and analyzed using high-performance liquid chromatography as described 
in Materials and Methods. Values are presented as means ± SEM (n = 3) Means 
with  different  letters  are significantly  different  (P < 0.001)  according  to  Duncan’s
multiple  range  test. 
(A)
(B)
Fig. 3. Altered levels of sphingoid base phosphates associated with 
keratinocyte differentiation.  Panel  A:  Sphingosine-1-phosphate;  Panel  B: 
Sphinganine-1-phosphate.  Sphingoid  base  phosphates  were  extracted  and 
dephosphorylated  using  an  alkaline  phosphatase  assay  from  keratinocytes grown 
in culture medium with 0.07 mM Ca
2+  (proliferation), 1.2 mM Ca
2+  (early diff.), and 
control  medium  containing  vitamin  C  (late  diff.)  and  then  analyzed  using 
high-performance  liquid  chromatography  as  described  in  Materials  and  Methods.
Values  are  presented  as  means ± SEM  (n = 3)  Means  with  different  letters  are 
significantly  different (P < 0.001)  according  to  Duncan’s  multiple  range  test.
Analysis of sphingoid bases
We first investigated the levels of C18 SO and C18 SA in the 
process of keratinocyte differentiation by generating three distinct 
keratinocyte differentiation stages (Fig. 2). Cells designated as 
being in the proliferation and early differentiation stage were 
prepared with 0.07 mM Ca
2+ and 1.2 mM Ca
2+, respectively, 
in serum-free culture medium. Late stage differentiated keratinocytes 
were cultured in serum-containing medium with vitamin C (50 
μL/mL) and 1.2 mM Ca
2+. Because of the large increase in the 
number of structural proteins (data not shown) known to 
characterize keratinocyte differentiation [24],
  the results were 
normalized with respect to DNA rather than protein content. 
Cellular levels of C18  SO and C18 Sa in keratinocytes increased 
dramatically when keratinocytes were induced into late differen-
tiation; a four-fold increase in So and a ten-fold increase in Sa 
were observed compared with the levels in the proliferation stage 
(P< 0.001) (Fig. 2). However, high Ca
2+ treatment alone did not 
increase the levels of SO or SA, suggesting that free sphingoid 
bases were required for late differentiation of keratinocytes. 
Analysis of sphingoid base 1-phosphates
Cellular levels of C18  S1P and SA1P per microgram of DNA 
were increased in keratinocytes induced into late differentiation 
by vitamin C in serum-containing medium, similar to the levels 
of their sphingoid bases. Compared with cells in the proliferation 
stage, S1P and SA1P levels decreased in early differentiation 
and then increased significantly when the cells progressed to late 
differentiation (P < 0.001) (Fig. 3).
Effect of vitamin C on ceramide metabolites
To demonstrate whether addition of vitamin C, which has been 
previously shown to increase the concentrations of other sphing-
olipids [6] and related enzymes, had an effect on the production 
of free sphingoid bases and their phosphates, keratinocytes were 
cultured in serum-containing medium with either vehicle or 
vitamin C (50 μL/mL). Although treatment with vitamin C 
moderately increased the productions of both C18 SO and C18 
SA, these increases were not statistically significant. In addition, 
productions of S1P and SA1P that were formed through the 
phosphorylation of C18 SO and C18 SA, respectively, by SO 
kinase also did not change in response to vitamin C (Fig. 4). 
The ratio of SO to SA during keratinocyte differentiation
Changes in sphingoid bases have recently been implicated in 
membrane permeability. In this study, we observed a marked 
change in the ratio of SO to SA during keratinocyte differentia-
tion. In basal cells and early differentiated cells, the ratios were 400 Analysis ceramide metabolites in calcium vitamin C
Fig. 4. Effect of vitamin C on production of ceramides metabolites. Sphingoid 
bases  and  their  phosphates  were  extracted  from  keratinocytes  grown  in 
serum-containing culture  medium  with  50 μg/mL  of vitamin  C  (Vit C ) o r w it h o u t 
(control) and were then analyzed by high-performance liquid chromatography. Values 
are  presented  as  means ± SEM  (n = 3). 
Fig. 5. The ratio of sphingosine (SO) to sphinganine (SA) during keratinocyte 
differentiation.  C18  sphingoid  bases  were  extracted  from  keratinocytes  grown  in 
culture  medium  with  0.07  mM  Ca
2+  (proliferation),  1.2  mM  Ca
2+( e a r l y  d i f f . ) ,  a n d  
control  medium  containing  vitamin  C  (late  diff.)  and  were  then  analyzed  using 
high-performance liquid chromatography. The ratios of SO to SA were compared 
during differentiation. Values are presented as means ± SEM (n = 3). Means with 
different letters are significantly different (P < 0.05) according to Duncan’s multiple 
range  test.
4.45 and 6.85, respectively. As the CHKs progressed into the 
late differentiation stage, the ratio decreased to 1.73 (Fig. 5).
Discussion
CHKs grown in culture medium with low Ca
2+ (0.02 to 0.1 
mM) continue to proliferate and maintain the morphologies of 
basal epidermal cells. When the extracellular Ca
2+ level is 
increased (from 1 to 2 mM), the cells stop differentiating and 
develop into an early differentiation stage that is accompanied 
by increased synthesis of sphingolipids [4,7,24]. Furthermore, 
when grown in serum-containing culture medium with vitamin 
C and a high concentration of Ca
2+, CHKs undergo late diff-
erentiation associated with the distribution of epidermal-like 
sphingolipids [6,19]. In the present study, we employed the same 
model for culturing differentiated keratinocytes as described in 
previous studies and expanded upon those studies to gain a better 
understanding of the relationship between sphingolipid metabolism 
and epidermal differentiation. Levels of C18 SO and C18  SA, S1P, 
and SA1P were analyzed during keratinocyte differentiation.
In this study, the overall amount of SO was greater than that 
of Sa, and both showed the same pattern during differentiation, 
even though SO (with a 4,5-trans double bond) has been 
considered a more active analog than SA (without a 4,5-trans 
double bond). SO and SA levels were dramatically increased in 
late differentiated cells grown in serum-containing medium with 
vitamin C and were present in low concentrations in the 
proliferative and early differentiation stages. In the basal layer 
of the epidermis, SO and S1P derived from ceramide hydrolysis 
have been shown to protect keratinocytes against cellular Cer 
accumulation, which is known to mediate cell apoptosis through 
oxidative stress. Other studies have also suggested that SO plays 
a role in cell proliferation through signaling pathways and, in 
turn, can be phosphorylated by SO kinase to form S1P, which 
is widely known for its anti-apoptotic effects in keratinocytes 
[25-27]. The activities of neutral and phytoalkaline ceramidases 
account for this finding [19]. However, in the early differentiation 
stage, induced by increasing the concentration of Ca
2+ (1.2 mM), 
the cells contained almost the same amounts of SO and SA as 
were present in the basal layer. When keratinocytes reach the 
SG containing high Ca
2+  concentrations, sphingoid bases are 
produced via a de novo biosynthetic pathway in which SA acts 
as a pathway intermediate, and SO is associated with sphingolipid 
and Cer degradation [24,28]. Prior studies revealed that treatment 
with a high concentration of extracellular Ca
2+ (1.8 mM) activates 
acid and alkaline ceramidases, both of which more efficiently 
hydrolyze SO-containing Cer than they do SA-containing Cer 
(dihydroceramides). In comparison, inhibition of alkaline ceramidase 
activity by a negative regulator such as epidermal growth factor 
(EGF) has also been proposed [29]. The fact that early 
differentiated cells were grown in medium containing both Ca
2+ 
and EGF supports this finding. Similar to our results, another 
study showed that mRNA levels for both acid and alkaline 
ceramidases were not altered in response to changes in Ca
2+ 
concentration [19]. On the other hand, sphingoid bases were 
much more abundant (P < 0.001) in late differentiated CHKs 
compared with proliferative and early differentiated cells. Increased 
levels of Cer in late differentiated cells account are shown in 
Fig. 3. The concentrations of Cer, the major components of the 
SC permeability barrier, were almost ten-fold higher than those 
of sphingoid bases [11]. Unrestricted Cer hydrolysis could 
threaten the lamellar structures of the SC, and the acid and 
alkaline ceramidases that require optimum pH conditions are 
reported to mediate this conversion [28,30,31]. Another recent 
study reported that acid and alkaline ceramidases have activities 
of 127 ± 63 pmol/mg of protein/h and 42 ± 16 pmol/mg of 
protein/h, respectively [19]. Moreover, the level of alkaline 
ceramidase mRNA was increased more than 100-fold in late 
differentiated CHKs compared with those in high Ca
2+-treated 
cells. Releases of SO and SA from Cer have also been shown 
to induce growth arrest or differentiation in keratinocytes [11]. 
Studies have suggested that vitamin C itself increases 
sphingolipid production by not only promoting the hydroxylation 
of sphingoid bases and free fatty acids of Cer but also enhancing Juyoung Kim et al. 401
the production of non-hydroxylated Cer and specific glucosy-
lceramides [5,6,31]. Therefore, we next investigated whether the 
vitamin C or the medium-containing serum enhanced the 
generation of ceramide metabolites. In a previous study, CHKs 
maintained in serum-containing medium with 1.2 mM Ca
2+ were 
more fully differentiated and had greater glucosylceramide 
production [6,32]. Likewise, in this study, we demonstrated 
higher levels of SO (3.8-fold increase) and SA (8.17-fold increase) 
in CHKs cultured in serum-containing medium than in basal cells. 
Vitamin C did not increase the production of SO or SA compared 
with vitamin C-untreated late differentiation of CHKs (control) 
(Fig. 4). However, vitamin C has been previously reported to 
enhance the preferential formation of Cer 2 and 5, which contain 
SO or SA as their backbone bases. Further research investigating 
the heterogeneity of ceramidases is needed to determine the 
consequences of sphingoid base production in response to 
vitamin C. Interestingly, the formation of acylCer is enhanced 
by vitamin C, leading to the release of free sphingoid bases and 
the ω-OH-FFA that is associated with the cornified envelope of 
SC corneocytes [6,33,34]. Generation of ω-OH-FFA has been 
observed in vitamin C-treated cells but not in controls. Additional 
studies investigating the role of dihydroceramide delta 4-5 
desaturase will be helpful to fully elucidate the effects of vitamin 
C on the production of C18 SO and C18 SA since this enzyme 
is a key regulator in SO production [35]. The ratio of SO to 
SA is also worth noting. as shown in Fig. 5, in basal cells and 
in the early differentiation stage, the SO:SA ratio was 4.45:6.85, 
respectively. As the cells progressed to late differentiated CHKs, 
the ratio decreased to 1.73. A significant increase in SA level 
in late differentiation might have resulted from its pro-differen-
tiation activity in CHKs. Interestingly, recent research has 
reported that the ratio of SO to SA is a critical determinant of 
membrane stability in atopic dermatitis. The epidermis of mice 
with skin disease presented a markedly increased ratio of 
5.5-15.2, suggesting that the higher ratio might contribute to 
barrier defects. In our study, the ratio was notably decreased in 
late differentiation, which is associated with a more rigid cell 
layer compared to all of the other epidermal cell layers [8,19]. 
On the other hand, another similar study showed that a lack of 
dihydroceramide delta 4-5 desaturase, which catalyzes the 
conversion of SA to SO in a de novo ceramide synthesis pathway, 
leads to scaly skin, suggesting that sphingoid bases are not only 
elements of Cer but are also essential for barrier function in the 
epidermis [9,36]. In the SC of the epidermis, C18 SO is known 
to exert powerful antimicrobial and anti-inflammatory effects by 
inhibiting protein kinase C activity [14,16,37]. In addition, SA 
also has also been reported to inhibit microbial adherence.
In this study, we showed similar results for C18  S1P and C18 
SA1P to those of their sphingoid base precursors in the course 
of keratinocyte differentiation. In the proliferative and early 
differentiation stages, levels of these phosphates remained low 
and then increased in the suprabasal layer. In serum-containing 
media with vitamin C and 1.2 mM Ca
2+, S1P and Sa1P levels 
increased by 4.56-fold and 5.60 fold, respectively, over those 
in serum-free medium with low Ca
2+. In addition, neither low 
nor high Ca
2+ treatment influenced the production of S1P or 
Sa1P. This finding is supported by previous studies demonstra-
ting that exogenous Ca
2+ has no effect on SO kinase, which 
converts sphingoid bases into their respective phosphates [38]. 
Interestingly, this enzyme is highly associated with Ca
2+ and has 
binding sites for calmodulin, leading to Ca
2+ mobilization in 
many different cell types [39,40]. Moreover, its activity increases 
the productions of differentiation markers such as involucrin, 
loricrin, filaggrin, and keratin 5, resulting in keratinocyte 
differentiation [26,41]. Consistent with this, we observed 
dramatic upregulations of C18 S1P and SA1P levels in late 
differentiated CHKs, which are thought to be derived from the 
activity of SO kinase and their precursors, C18 SO and C18  SA, 
respectively. S1P has been considered a significant factor 
involved in motility and morphological change in human cells 
such as arterial smooth muscle cells, endothelial cells, and 
keratinocytes [17,42-45]. S1P may regulate the morphological 
changes associated with differentiation since morphological 
changes in keratinocytes are concomitant with keratinocyte 
differentiation. On the other hand, treatment with vitamin C did 
not increase the production of these sphingoid base phosphates, 
suggesting that SO kinase was inactive despite the presence of 
vitamin C. However, we cannot confirm that the SO kinase was 
inactive since its activity was not investigated in this study. 
In conclusion, we demonstrated that Cer metabolites, specifically 
C18 SO, C18 SA, C18 S1P, and C18 SA1P, were significantly 
increased in late but not early stage differentiated CHKs, 
suggesting that not only Cer but also high levels of their 
metabolites are required for late differentiation of keratinocytes. 
However, vitamin C, which is known to increase Cer production 
[6], did not stimulate the generation of C18 SO, C18 SA, C18 S1P, 
or C18 SA1P. 
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